Predictions
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€36.50
22.08.22
22.08.22
€66.00
22.08.23
22.08.23
-8.22%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€25.58
22.08.22
22.08.22
€44.00
22.08.23
22.08.23
-5.00%
03.09.22
03.09.22
Could be very worthwhile Investment >20% year
Capable Management
Good culture
Innovative
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€98.65
04.01.22
04.01.22
-
04.01.23
04.01.23
-56.84%
25.08.22
25.08.22
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€98.65
04.01.22
04.01.22
-
04.01.23
04.01.23
-56.84%
25.08.22
25.08.22
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€35.03
23.12.21
23.12.21
-
23.12.22
23.12.22
-28.09%
25.08.22
25.08.22
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€126.20
24.08.21
24.08.21
-
24.08.22
24.08.22
-67.27%
24.08.22
24.08.22
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€126.20
24.08.21
24.08.21
-
24.08.22
24.08.22
-67.27%
24.08.22
24.08.22
Stratec SE
Start price
Target price
Perf. (%)
€85.00
26.07.22
26.07.22
€66.00
26.07.23
26.07.23
4.94%
06.08.22
06.08.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€147.00
01.02.22
01.02.22
€180.00
01.08.22
01.08.22
-3.71%
01.08.22
01.08.22
Could be very worthwhile Investment >20% year
Standard Investments for future growth
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€147.00
01.02.22
01.02.22
€180.00
01.08.22
01.08.22
-3.71%
01.08.22
01.08.22
Could be very worthwhile Investment >20% year
Standard Investments for future growth
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.70
27.01.22
27.01.22
€42.00
27.07.22
27.07.22
-24.49%
27.07.22
27.07.22
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital